Meeting
2024 ASCO Annual Meeting
Impact of microbiota specific circulating memory T cells in response to immunotherapy.
Authors
Federica Gattazzo
Catholic University of Sacred Heart, Milan, Italy
Federica Gattazzo , Roxanne Birebent , Isabelle Lebhar , Marie Xiberras , Mathias Marques , Anna Reni , Caroline Flament , Adele Bonato , Lorenzo Belluomini , Hugo Chanfreau-Paris , Agathe Carrier , Benjamin Besse , Laurence Albiges , Jordi Ramon , Claudia Parisi , Marie Deroussent , Franck Berthier , Carolina Alves Costa Silva , Lisa Derosa , Laurence Zitvogel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Circulating Biomarkers
Clinical Trial Registration Number
NCT04567446
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 2572)
DOI
10.1200/JCO.2024.42.16_suppl.2572
Abstract #
2572
Poster Bd #
51
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
FDA pooled analysis of overall survival according to depth of response as a continuous variable in frontline advanced immuno-oncology renal cell carcinoma trials.
First Author: Elaine Chang
Poster
2024 ASCO Genitourinary Cancers Symposium
Topological heterogeneity of genomic and immunologic effects from combination immunotherapy treatment in the neoadjuvant setting for renal cell carcinoma (RCC).
First Author: Tyler Alban
Poster
2023 ASCO Genitourinary Cancers Symposium
The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups and correlates with gut microbiota (GM) in patients with advanced renal cell carcinoma (RCC).
First Author: Carolina Alves Costa Silva
Poster
2022 ASCO Annual Meeting
Identification of super-exhausted T cells: A novel population predictive of response to immunotherapy.
First Author: Florent Peyraud